Product Code: GVR-4-68040-306-8
Fat Cavitation Market Growth & Trends:
The global fat cavitation market size is anticipated to reach USD 664.9 million by 2030 and is projected to grow at a CAGR of 10.6% from 2024 to 2030, based on a new report by Grand View research, Inc. The market growth is attributed to the changing aesthetic needs, increasing availability to finance invasive and non-invasive cosmetic surgeries, and growing collaboration between manufacturers and other service intermediaries.
The availability to finance cosmetic surgeries at distributed monthly cost propels patients to undergo cosmetic procedures such as fat cavitation in developed countries such as the U.S. and Germany. For instance, in April 2022, PatientFi and Allergan Aesthetics expanded their marketing agreement, allowing the former company to provide financing options to the latter's product portfolio.
In addition, obesity rates across the world are expected to create opportunities for the global market. According to an article released by the World Obesity Federation in May 2022, nearly one billion people around the globe are likely to develop obesity by 2030. The prevalence of obesity is estimated to be nearly 1 in 5 for women and 1 in 7 for men.
Fat Cavitation Market Report Highlights:
- The global market size was estimated at USD 363.3 million in 2023 and is expected to reach 664.9 USD million in 2030
- The global market is expected to grow at a CAGR of 10.6% from 2024 to 2030
- Based on gender, the female segment led the market with the largest revenue share of 82.7% in 2023. It is due to high acceptability of cosmetic procedures in women than men
- Based on application, the abdomen segment led the market with the largest revenue share of 27.84% in 2023. Genetics, lifestyle choices, and hormonal changes contribute to the development of stubborn fat deposits in this area
- Based on end-use, the medspas segment led the market with the largest revenue share of 47.3% in 2023, due to the availability of advanced infrastructure, shorter waiting time, and the ability to serve patients on an outpatient preference
- North America dominated the market with the revenue share of 43.08% in 2023. This growth can be attributed to the increasing acceptability of cosmetic procedures, growing product approvals from federal regulatory bodies, and availability of financing options
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Application
- 1.2.2. Gender
- 1.2.3. End Use
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity price analysis (Model 1)
- 1.7.2. Approach 1: Volume price approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.2.2. Gender outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Fat Cavitation Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Fat Cavitation Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Fat Cavitation Market: Application Estimates & Trend Analysis
- 4.1. Fat Cavitation Market: Application Dashboard
- 4.2. Fat Cavitation Market: Application Movement Analysis
- 4.3. Fat Cavitation Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 4.4. Abdomen
- 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Hips
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Thighs
- 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Others
- 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Fat Cavitation Market: Gender Estimates & Trend Analysis
- 5.1. Fat Cavitation Market: Gender Dashboard
- 5.2. Fat Cavitation Market: Gender Movement Analysis
- 5.3. Fat Cavitation Market Size & Forecasts and Trend Analysis, by Gender, 2018 to 2030 (USD Million)
- 5.4. Female
- 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Male
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Fat Cavitation Market: End-use Estimates & Trend Analysis
- 6.1. Fat Cavitation Market: End-use Dashboard
- 6.2. Fat Cavitation Market: End-use Movement Analysis
- 6.3. Fat Cavitation Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
- 6.4. Cosmetic Surgery Centers
- 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Medspas
- 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Hospitals and others
- 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Fat Cavitation Market: Regional Estimates & Trend Analysis by Country, Application, Gender, and End-use.
- 7.1. Fat Cavitation Market: Regional Dashboard
- 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/ reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Regulatory framework/ reimbursement structure
- 7.3.4.3. Competitive scenario
- 7.3.4.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.8. Norway
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.9. Denmark
- 7.4.9.1. Key country dynamics
- 7.4.9.2. Regulatory framework/ reimbursement structure
- 7.4.9.3. Competitive scenario
- 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.3. Japan
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.7. South Korea
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework/ reimbursement structure
- 7.5.7.3. Competitive scenario
- 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7. MEA
- 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.3. South Africa
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework/ reimbursement structure
- 7.7.5.3. Competitive scenario
- 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Olympia Medical Spa
- 8.3.3.1. Company overview
- 8.3.3.2. Type benchmarking
- 8.3.3.3. Strategic initiatives
- 8.3.4. Beverly Hills Med Spa
- 8.3.4.1. Company overview
- 8.3.4.2. Type benchmarking
- 8.3.4.3. Strategic initiatives
- 8.3.5. Beauty Loft Spa
- 8.3.5.1. Company overview
- 8.3.5.2. Type benchmarking
- 8.3.5.3. Strategic initiatives
- 8.3.6. New York Dermatology Group
- 8.3.6.1. Company overview
- 8.3.6.2. Type benchmarking
- 8.3.6.3. Strategic initiatives
- 8.3.7. Skin Envy
- 8.3.7.1. Company overview
- 8.3.7.2. Type benchmarking
- 8.3.7.3. Strategic initiatives
- 8.3.8. CLIPP Laser Center
- 8.3.8.1. Company overview
- 8.3.8.2. Type benchmarking
- 8.3.8.3. Strategic initiatives
- 8.3.9. The Harley Street Clinic
- 8.3.9.1. Company overview
- 8.3.9.2. Type benchmarking
- 8.3.9.3. Strategic initiatives
- 8.3.10. Juvea Aesthetics
- 8.3.10.1. Company overview
- 8.3.10.2. Type benchmarking
- 8.3.10.3. Strategic initiatives
- 8.3.11. VIVO Clinic
- 8.3.11.1. Company overview
- 8.3.11.2. Type benchmarking
- 8.3.11.3. Strategic initiatives
- 8.3.12. Skin Tech
- 8.3.12.1. Company overview
- 8.3.12.2. Type benchmarking
- 8.3.12.3. Strategic initiatives